OrganiGram Holdings Inc - Asset Resilience Ratio
OrganiGram Holdings Inc (OGI) has an Asset Resilience Ratio of 0.16% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is OrganiGram Holdings Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how OrganiGram Holdings Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see OGI current and non-current assets.
Liquid Assets Composition Over Time
This chart breaks down OrganiGram Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore OrganiGram Holdings Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 0% |
| Short-term Investments | CA$811.00K | 0.16% |
| Total Liquid Assets | CA$811.00K | 0.16% |
Asset Resilience Insights
- Limited Liquidity: OrganiGram Holdings Inc maintains only 0.16% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
OrganiGram Holdings Inc Industry Peers by Asset Resilience Ratio
Compare OrganiGram Holdings Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 0.50% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Neuland Laboratories Limited
NSE:NEULANDLAB |
Drug Manufacturers - Specialty & Generic | 9.65% |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062 |
Drug Manufacturers - Specialty & Generic | 1.18% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
Annual Asset Resilience Ratio for OrganiGram Holdings Inc (2016–2025)
The table below shows the annual Asset Resilience Ratio data for OrganiGram Holdings Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-09-30 | 0.15% | CA$826.00K ≈ $597.52K |
CA$562.21 Million ≈ $406.69 Million |
-0.05pp |
| 2024-09-30 | 0.20% | CA$821.00K ≈ $593.90K |
CA$407.86 Million ≈ $295.04 Million |
-- |
| 2023-09-30 | 0.00% | CA$0.00 ≈ $0.00 |
CA$298.45 Million ≈ $215.90 Million |
-- |
| 2022-09-30 | 5.27% | CA$30.40 Million ≈ $21.99 Million |
CA$577.11 Million ≈ $417.47 Million |
-17.92pp |
| 2021-09-30 | 23.19% | CA$128.48 Million ≈ $92.94 Million |
CA$554.02 Million ≈ $400.77 Million |
+11.19pp |
| 2020-09-30 | 12.00% | CA$50.13 Million ≈ $36.26 Million |
CA$417.62 Million ≈ $302.10 Million |
+11.91pp |
| 2019-09-30 | 0.09% | CA$380.00K ≈ $274.89K |
CA$428.52 Million ≈ $309.99 Million |
-24.70pp |
| 2018-09-30 | 24.79% | CA$75.00 Million ≈ $54.25 Million |
CA$302.57 Million ≈ $218.87 Million |
-9.69pp |
| 2017-09-30 | 34.48% | CA$32.00 Million ≈ $23.15 Million |
CA$92.81 Million ≈ $67.14 Million |
-7.80pp |
| 2016-09-30 | 42.28% | CA$22.77 Million ≈ $16.48 Million |
CA$53.87 Million ≈ $38.97 Million |
-- |
About OrganiGram Holdings Inc
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Ediso… Read more